Pfizer Inc. PFE.NE Stock
Pfizer Inc. Price Chart
Pfizer Inc. PFE.NE Financial and Trading Overview
Pfizer Inc. stock price | 13.42 CAD |
Previous Close | 18.65 CAD |
Open | 18.62 CAD |
Bid | 18.79 CAD x N/A |
Ask | 18.86 CAD x N/A |
Day's Range | 18.62 - 18.85 CAD |
52 Week Range | 17.18 - 26.1 CAD |
Volume | 10.39K CAD |
Avg. Volume | 22.49K CAD |
Market Cap | 307.18B CAD |
Beta (5Y Monthly) | 0.589084 |
PE Ratio (TTM) | 7.3346305 |
EPS (TTM) | -0.03 CAD |
Forward Dividend & Yield | 0.76 (4.00%) |
Ex-Dividend Date | May 11, 2023 |
1y Target Est | N/A |
PFE.NE Valuation Measures
Enterprise Value | 437.6B CAD |
Trailing P/E | 7.3346305 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 3.3047884 |
Price/Book (mrq) | 4.215352 |
Enterprise Value/Revenue | 4.708 |
Enterprise Value/EBITDA | 10.769 |
Trading Information
Pfizer Inc. Stock Price History
Beta (5Y Monthly) | 0.589084 |
52-Week Change | -16.17% |
S&P500 52-Week Change | 20.43% |
52 Week High | 26.1 CAD |
52 Week Low | 17.18 CAD |
50-Day Moving Average | 18.56 CAD |
200-Day Moving Average | 21 CAD |
PFE.NE Share Statistics
Avg. Volume (3 month) | 22.49K CAD |
Avg. Daily Volume (10-Days) | 16.39K CAD |
Shares Outstanding | 14.66B |
Float | 22.56B |
Short Ratio | N/A |
% Held by Insiders | N/A |
% Held by Institutions | N/A |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.61 |
Trailing Annual Dividend Yield | 8.63% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.2978 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | April 2, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 31.25% |
Operating Margin (ttm) | 37.99% |
Gross Margin | 68.93% |
EBITDA Margin | 43.71% |
Management Effectiveness
Return on Assets (ttm) | 11.63% |
Return on Equity (ttm) | 31.61% |
Income Statement
Revenue (ttm) | 92.95B CAD |
Revenue Per Share (ttm) | 4.14 CAD |
Quarterly Revenue Growth (yoy) | -28.79% |
Gross Profit (ttm) | 66.23B CAD |
EBITDA | 40.64B CAD |
Net Income Avi to Common (ttm) | 29.03B CAD |
Diluted EPS (ttm) | 2.57 |
Quarterly Earnings Growth (yoy) | -29.50% |
Balance Sheet
Total Cash (mrq) | 19.97B CAD |
Total Cash Per Share (mrq) | 0.88 CAD |
Total Debt (mrq) | 36.17B CAD |
Total Debt/Equity (mrq) | 35.72 CAD |
Current Ratio (mrq) | 1.37 |
Book Value Per Share (mrq) | 4.47175 |
Cash Flow Statement
Operating Cash Flow (ttm) | 23.94B CAD |
Levered Free Cash Flow (ttm) | 17.96B CAD |
Profile of Pfizer Inc.
Country | Canada |
State | NY |
City | New York |
Address | 66 Hudson Boulevard East |
ZIP | 10001-2192 |
Phone | 212 733 2323 |
Website | https://www.pfizer.com |
Industry | Drug Manufacturers-General |
Sector(s) | Healthcare |
Full Time Employees | 83000 |
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Q&A For Pfizer Inc. Stock
What is a current PFE.NE stock price?
Pfizer Inc. PFE.NE stock price today per share is 13.42 CAD.
How to purchase Pfizer Inc. stock?
You can buy PFE.NE shares on the Cboe CA exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pfizer Inc.?
The stock symbol or ticker of Pfizer Inc. is PFE.NE.
Which industry does the Pfizer Inc. company belong to?
The Pfizer Inc. industry is Drug Manufacturers-General.
How many shares does Pfizer Inc. have in circulation?
The max supply of Pfizer Inc. shares is 16.43B.
What is Pfizer Inc. Price to Earnings Ratio (PE Ratio)?
Pfizer Inc. PE Ratio is now.
What was Pfizer Inc. earnings per share over the trailing 12 months (TTM)?
Pfizer Inc. EPS is -0.03 CAD over the trailing 12 months.
Which sector does the Pfizer Inc. company belong to?
The Pfizer Inc. sector is Healthcare.